TDACFinancial Services · Shell Companies

TDAC Stock Forecast: Translational Development Acquisition Corp. Price Predictions for 2026-2027

Last close, 15 Oct 2026

$11

+0.14% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 72 of 100 as at 14 Oct 2026 — in the upper half.

Market cap

$209.1M

Ticker Nerd rank

72 / 100

Median analyst target

—

Analysts covering

—

Revenue$0.0

Operating income−$661K

Net income$947K

Free cash flow−$339K

Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown

Total return, dividends reinvested

+0.1%

−0.7%

YTD

+3.2%

+4.3%

From 52W high

−0.7%

From 52W low

+4.3%

$10

$11

52-week range, adjusted closes · the dot is the last close

Ticker Nerd rank

TDAC stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Translational Development Acquisition Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 14 Oct 2026

72 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Momentum

Volatility

Value

Accruals

Size

Quality

Issuance

Revisions

Growth

Momentum (98): The shares have been drifting up relative to others.

Growth (23): Sales and profits are flat, shrinking, or growing more slowly than they were.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

TDAC stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on TDAC, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Recent analyst actionsNewest first

Date	Firm	Action	Rating	Target
21 Sept 2021	Northland Capital Markets	Initiates	Outperform	$16

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. TDAC appears on the weeks it earns a place.

Performance

TDAC vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 15 Oct 2026, Translational Development Acquisition Corp. returned +4.3% against +17.3% for the S&P 500, dividends included.

TDAC vs S&P 500, last 12 monthsTotal return, rebased to 100

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

TDAC analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Translational Development Acquisition Corp. (TDAC) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: 41.7×
Price / sales: —
Price / book: 1.6×
EV / EBITDA: −25.5×

Growth & margins

Revenue growth (YoY): —
Earnings growth (YoY): −41.7%
Gross margin: —
Operating margin: 0.0%
Net margin: 0.0%

Returns & dividend

Return on equity: 3.6%
Return on assets: −0.5%
Dividend yield: 0.0%

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Translational Development Acquisition Corp. (TDAC) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

Translational Development Acquisition Corp. has a market value of $209.1M and an enterprise value of $210.1M.
Revenue in the twelve months to 30 June 2026: $0.0.
Net income over the same four quarters: $5.5M.
Free cash flow in the twelve months to 30 June 2026: −$849K.
Shares outstanding: 19.3M.
Trailing P/E: 41.7×; forward P/E: 378.5× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
Translational Development Acquisition Corp. employs 0 people.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 14 Oct 2026

Data provided by Twelve Data

Peers

TDAC vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelShell Companies

Company	Market cap	TKN rank
TDACTranslational Development Acquisition Corp.	$209.1M	72
THEOBOA Acquisition Corp. II	$205.9M	5
IDACIron Dome Acquisition I Corp.	$211.8M	10
WLIIWillow Lane Acquisition Corp. II	$205.5M	12
HAVAHarvard Ave Acquisition Corp.	$212.5M	11
PALOPaloma Acquisition Corp. I	$212.7M	9
AACPApogee Acquisition Corp.	$213.9M	15

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Translational Development Acquisition Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest TDAC news & analysis

ProLogium Unveils DCN, Opening a “Third State” Electrolyte Universe at Paris Motor Show

GlobeNewsWire · 8 Oct 2026neutral

ProLogium said it will unveil its Dynamic Coordination Network (DCN) electrolyte architecture at the 2026 Paris Motor Show. The company describes its GEN4 technology as using a Superfluidized Inorganic Electrolyte to create dynamic lithium-ion transport pathways.

Why it matters — The announcement concerns battery technology and manufacturing developments that may be relevant to TDAC watchers following the automotive and energy-storage sectors.

Mercedes-Benz and ProLogium have entered into a joint testing agreement, including a preliminary technology evaluation of ProLogium's latest Gen4 Superfluidized All Inorganic Solid State Battery Cell Technology

GlobeNewsWire · 24 Sept 2026positive

Mercedes-Benz AG and ProLogium Holding Inc. have signed a joint testing agreement, giving Mercedes-Benz priority access to evaluate ProLogium's latest Gen4 Superfluidized All Inorganic Solid State Battery Cell Technology. The agreement extends their nearly ten-year partnership in advancing next-generation battery technologies for mobility.

Why it matters — A TDAC watcher would care because this partnership signals ongoing commercial validation of ProLogium's solid-state battery technology by a major automaker, potentially advancing the battery-tech landscape TDAC tracks.

Kyushu Electric Power Advances Strategic Investment in ProLogium, Deepening Collaboration in Next-Generation Batteries and Energy Sector

GlobeNewsWire · 9 Sept 2026positive

Kyushu Electric Power is advancing from an existing collaboration with ProLogium in energy and next-generation batteries toward capital participation in the company. The move is expected to strengthen ProLogium's long-term engagement with Japan's industrial ecosystem.

Why it matters — A TDAC watcher would be interested because deepened engagement between a major Japanese utility and a next-generation battery developer signals growing institutional interest and an expanding collaborative footprint in the energy sector.

ProLogium Appoints Antony Sheriff, CEO of Rimac Group, to Board of Directors

GlobeNewsWire · 24 Aug 2026positive

ProLogium announced the appointment of Antony Sheriff, CEO of Rimac Group, to its board of directors, effective upon closing of its previously announced business combination agreement with Translational Development Acquisition Corp. (Nasdaq: TDAC). Sheriff brings nearly four decades of automotive and advanced manufacturing leadership experience.

Why it matters — For TDAC watchers, this adds a seasoned automotive and manufacturing executive to ProLogium's board ahead of the closing of the business combination with TDAC.

Translational Development Investor Alert: Kahn Swick & Foti, LLC Investigates Translational Development Acquisition Corp. - TDAC

Business Wire · 19 Aug 2026negative

Kahn Swick & Foti, LLC, led by former Louisiana Attorney General Charles C. Foti Jr., is investigating the proposed merger between Translational Development Acquisition Corp. (TDAC) and Prologium Holding Inc. The law firm is examining whether the merger process was adequate and whether the deal is fair to Translational shareholders.

Why it matters — TDAC watchers would care because a law firm is scrutinizing the fairness of the proposed merger, which could raise concerns about the deal's terms and process for shareholders.

FAQ

Frequently asked questions about TDAC stock

How does Ticker Nerd's model rank TDAC?

As at 14 Oct 2026, Translational Development Acquisition Corp. ranks 72 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (98 of 100).

What is the TDAC stock forecast for 2030?

No analyst covering Translational Development Acquisition Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for TDAC are extrapolating price history, which says nothing about the business.

How has TDAC stock performed over the past year?

Translational Development Acquisition Corp. returned +4.3% over the 12 months to 15 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Translational Development Acquisition Corp. do?

What is the latest news on TDAC?

The most recent item we track (GlobeNewsWire, 8 Oct 2026): "ProLogium Unveils DCN, Opening a “Third State” Electrolyte Universe at Paris Motor Show". ProLogium said it will unveil its Dynamic Coordination Network (DCN) electrolyte architecture at the 2026 Paris Motor Show. The company describes its GEN4 technology as using a Superfluidized Inorganic Electrolyte to create dynamic lithium-ion transport pathways.

Company

About Translational Development Acquisition Corp.

Translational Development Acquisition Corp. is a special purpose acquisition company, or blank check company, focused on completing a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Based in New York, the company does not operate a traditional commercial business and instead serves as a capital-market vehicle for identifying and combining with a target company. Its structure is commonly used to help private businesses access public markets through a transaction rather than a conventional initial public offering. Translational Development Acquisition Corp. is currently associated with a proposed combination involving ProLogium, a next-generation battery company, reflecting its role in facilitating public-market listings for selected operating businesses.

CEO Mr. Michael M. B. Hoffman J.D. · United States · https://www.translational-development.com